NewAmsterdam Pharma Co. NV (NAMS)
33.76
-0.38
(-1.13%)
USD |
NASDAQ |
May 19, 16:00
33.76
0.00 (0.00%)
After-Hours: 17:55
NewAmsterdam Pharma EPS Diluted (Quarterly) : -0.398 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -0.8532 |
| ProQR Therapeutics NV | -0.1486 |
| argenx SE | -- |
| Pharming Group NV | -0.0746 |
| Arcutis Biotherapeutics, Inc. | -0.0873 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.44M |
| Revenue (Quarterly) | 3.04M |
| Total Expenses (Quarterly) | 51.48M |
| Enterprise Value | 3.354B |
| Gross Profit Margin (Quarterly) | 97.96% |
| Profit Margin (Quarterly) | -1.59K% |
| Earnings Yield | -5.35% |
| Normalized Earnings Yield | -4.800 |